[1]
Shrestha, R. 2020. Induced pluripotent stem cells are Japanese brand sources for therapeutic cells to pretrial clinical research. Progress in Stem Cell. 7, 1 (Jun. 2020), 296-303. DOI:https://doi.org/https://doi.org/10.15419/psc.v7i1.409.